109132 ⎘
Structure or type of the nucleic acid; Type of nucleic acid Antisense
USP30 INHIBITORS AND METHODS OF USE
#3602Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
#3603Compounds and methods for modulating gene expression
#3604Methods for creating bilayers for use with nanopore sensors
#3605Oligonucleotide compositions and methods of making the same
#3606Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field
#3607Methods And Compositions For Prevention Or Treatment Of RSV Infection Using Modified Duplex RNA Molecules
#3608Splice modulating oligonucleotides that inhibit cancer
#3609Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
#3610Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#3611Methods and compositions for modulating apolipoprotein (a) expression
#3612METHODS TO TREAT ALZHEIMER'S DISEASE USING APOE INHIBITORS
#3613Methods of treating an overweight subject
#3614Methods of treating ischemia-reperfusion injury with siRNAs
#3615SELECTIVE REDUCTION OF ALLELIC VARIANTS
#3616MODULATION OF MYOFIBER REPAIR BY ANTI-MYOSTATIN STRATEGIES AND/OR PPAR GAMMA LIGANDS, ALONE OR IN COMBINATION WITH STEM CELLS, FOR THE THERAPY OF CRITICAL LIMB ISCHEMIA AND OTHER ISCHEMIC PROCESSES AFFECTING THE SKELETAL MUSCLE
#3617Systems and methods for diagnosing and treating cancer
#3618SATB1: A DETERMINANT OF MORPHOGENESIS AND TUMOR METASTATIS
#3619Modified oligonucleotides for telomerase inhibition
#3620Modified oligonucleotides for telomerase inhibition
#3621Oligomeric compounds and compositions for the use in modulation of micrornas
#3622INDUCTION OF EXON SKIPPING IN EUKARYOTIC CELLS
#3623SNPs OF APOLIPOPROTEIN B AND MODULATION OF THEIR EXPRESSION
#3624COMPOUNDS AND METHODS FOR IMPROVED CELLULAR UPTAKE OF ANTISENSE COMPOUNDS
#3625Cancer treatment and immune system regulation through FAT10 pathway inhibition
#3626Manipulation of hairy and enhancer of split 3 (Hes3) and its regulators/mediators as an anti-cancer strategy
#3627Impaired wound healing compositions and treatments
#3628Antisense modulation of PTP1B expression
#3629Compositions and Methods for Modulation of ATXN3 Expression
#3630Compositions and methods for modulating angiopoietin-like 3 expression
#3631Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for usher syndrome
#3632Methods of delivering multiple targeting oligonucleotides to a cell using cleavable linkers
#3633Multimeric oligonucleotides compounds having cleavable linkers
#3634METHODS OF DELIVERING MULTIPLE TARGETING OLIGONUCLEOTIDES TO A CELL USING NON-NUCLEOTIDE BASED CLEAVABLE LINKERS
#3635Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers
#3636Deep intronic target for splicing correction on spinal muscular atrophy gene
#3637COMPOUNDS AND METHODS FOR IMPROVING CELLULAR UPTAKE OF OLIGOMERIC COMPOUNDS
#3638Compositions and methods for selective delivery of oligonucleotide molecules to cell types
#3639Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation
#3640Method for treating heart disease by inhibiting the Coxsackievirus-Adenovirus Receptor
#3641METHODS AND COMPOSITIONS FOR CONTROLLING PLANT VIRAL INFECTION
#3642Compositions and methods for modulation of FGFR3 expression
#3643ANOIKIS RESISTANT PLACENTAL STEM CELLS AND USES THEREOF
#3644RNA interference agent, method for producing same, and use therefor
#3645Compositions and their uses directed to huntingtin
#3646COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS
#3647Modulation of Hematopoietic Stem Cell Differentiation
#3648Composition for treating cancer associated with HPV infection
#3649Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
#3650Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
#3651METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES
#3652Multimeric oligonucleotides compounds
#3653EGVII Endoglucanase and Nucleic Acids Encoding the Same
#3654Compositions and methods for inhibiting viral entry
#3655MODULATION OF RENIN-ANGIOTENSIN SYSTEM (RAS) RELATED DISEASES BY ANGIOTENSINOGEN
#3656Methods and Compositions for treatment of cancer by inhibition of NR2F2
#3657Methods and Compositions for treatment of cancer by inhibition of NR2F6
#3658MODULATION OF CD40 EXPRESSION
#3659ANTI APOB ANTISENSE CONJUGATE COMPOUNDS
#3660RNA TARGETED TO BETA CATENIN
#3661Antisense compounds targeting genes associated with fibronectin
#3662Methods of treating kennedy's disease
#3663Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)
#3664Methods and compositions for use in treatment of FOXP2-related cancers
#3665Therapeutics with conformationally restricted monomers
#3666Oligonucleotide complex compositions and methods of use as gene alteration tools
#3667BGL7 Beta-Glucosidase and Nucleic Acids Encoding the Same
#3668Synergistic anti-cancer composition and a process for the preparation thereof
#3669Oligonucleotide conjugates
#3670SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF
#3671Methods for modulating Tau expression for reducing seizure and modifying a neurodegenerative syndrome
#3672Antisense antiviral compounds and methods for treating a filovirus infection
#3673TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) INJURY
#3674Means and methods for modulating NOTCH3 protein expression and/or the coding region of NOTCH3; compositions and use thereof in the treatment of CADASIL
#3675Triazine cationic polymers and methods of use thereof
#3676Methods and compositions for plant pest control
#3677Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)
#3678Antisense antiviral compound and method for treating ss/RNA viral infection
#3679METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS
#3680Methods for modulating C9ORF72 expression
#3681Oligomeric compounds comprising bicyclic nucleosides and uses thereof
#3682Composition and methods for the prevention and treatment of diet-induced obesity
#3683Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)
#3684Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2
#3685Oligomeric compounds comprising tricyclic nucleosides and methods for their use
#3686Nucleic acid functionalized nonoparticles for therapeutic applications
#3687Compositions for modulating C9ORF72 expression
#3688Double-stranded nucleic acid compounds
#3689CLUSTER OF DIFFERENTIATION 36 (CD36) AS A THERAPEUTIC TARGET FOR HIV INFECTION
#3690Modulation of transthyretin expression
#3691Identification and use of target genes for control of plant parasitic nematodes
#3692Compositions and methods for modulating SMN gene family expression
#3693RNA trans-splicing molecule (RTM) for use in the treatment of cancer
#3694Method for the treatment of cardiovascular fibrosis
#3695Piggy back delivery of nucleic acids into organisms
#3696METHODS FOR MODULATING RNA USING 3' TARGETING OLIGONUCLEOTIDES
#3697METHODS FOR MODULATING RNA USING PSEUDOCIRCULARIZATION OLIGONUCLEOTIDES
#3698ANTISENSE COMPOUNDS HAVING ENHANCED ANTI-MICRORNA ACTIVITY
#3699MULTIMERIC OLIGONUCLEOTIDE COMPOUNDS
#3700Muteins of the pyrroline-5-carboxylate reductase 1
#3701Pain treatment using ERK2 inhibitors
#3702MSF REPROGRAMS MYOFIBROBLASTS TOWARD LACTATE PRODUCTION AND FUEL ANAERBOIC TUMOR GROWTH
#3703THERAPEUTIC RNA SWITCHES COMPOSITIONS AND METHODS OF USE
#3704Recombinant RNA particles and methods of use
#3705Methods for producing a population of pancreatic beta-cells
#3706Use of regulatory T cell-specific surface protein LRIG-1
#3707Peptide-linked morpholino antisense oligonucleotides for treatment of myotonic dystrophy
#3708POLYMERIC CARRIER
#3709Euchromatic region targeting methods for modulating gene expression
#3710Oligonucleotide—containing pharmacological compositions and their use
#3711Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#3712Antisense compositions and methods of making and using same
#3713Treatment of insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to IRS2 and transcription factor E3 (TFE3)
#3714Compositions and methods for treatment of prostate and other cancers
#3715Treatment of fibrotic conditions
#3716Splice-region antisense composition and method
#3717COMPOSITIONS AND METHODS FOR MODULATING GENE EXPRESSION
#3718POLYNUCLEOTIDE-POLY(DIOL) CONJUGATES, PROCESS OF PREPARATION AND USES THEREOF
#3719Amphoteric liposomes
#3720Antisense polynucleotides to induce exon skipping and methods of treating dystrophies
#3721Selective reactivation of genes on the inactive X chromosome
#3722TREATMENT OF NEUROLOGICAL DISORDERS
#3723Inhibition of diacylglycerol kinase to augment adoptive T cell transfer
#3724WOUND TREATMENT
#3725Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field
#3726COMPOSITIONS FOR MODULATING GENE EXPRESSION
#3727MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE
#3728MicroRNA compounds and methods for modulating miR-21 activity
#3729Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis
#3730GENES OF AN OTITIS MEDIA ISOLATE OF NONTYPEABLE HEAMOPHILUS INFLUENZAE
#3731INHIBITORS OF ALPHA6 INTEGRIN/E-CADHERIN COMPLEX
#3732Nucleic acids targeting TCTP for use in the treatment of chemo- or hormone-resistant cancers
#3733Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field
#3734Restoration of the CFTR function by splicing modulation
#3735Chiral control
#3736Therapeutic method for pancreatic cancer
#3737Oligonucleotide comprising an inosine for treating DMD
#3738CTLA-4 aptamer siRNA species
#3739Treatment of Myelodysplastic Syndrome by Inhibition of NR2F6
#3740IMMUNE SYSTEM MEDIATOR
#3741Treatment of spinal cord injury or traumatic brain injury by inhibition of synuclein protein aggregation
#3742Treatment of ‘IQ motif containing gtpase activating protein’ (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAP
#3743Oligonucleotides for making a change in the sequence of a target RNA molecule present in a living cell
#3744Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression
#3745Sense oligonucleotide capable of controlling the expression of INOS and composition comprising the same
#3746Composition comprising material for inhibiting SCF or receptor thereof for treating or preventing diseases associated with vascular permeability
#3747Recombinant DNA for gene suppression
#3748Oligonucleotide for the Treatment of Muscular Dystrophy Patients
#3749U1 snRNP regulates gene expression and modulates oncogenicity
#3750Modulation of UBE3A-ATS expression
#3751WOUND HEALING
#3752Immunosuppression compound and treatment method
#3753ANTISENSE MODULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR 4 EXPRESSION
#3754Diagnostic and screening methods for atopic dermatitis
#3755Antisense Oligonucleotides Against Neutral Sphingomyelinase and Neutral Sphingomyelinase Inhibitor GW4869 for Degenerative Neurological Disorders
#3756Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#3757MODULATION OF TRANSTHYRETIN EXPRESSION
#3758MODULATION OF APOLIPOPROTEIN (a) EXPRESSION
#3759METHODS FOR PREVENTING AND TREATING CHRONIC KIDNEY DISEASE (CKD)
#3760Oligomeric compounds comprising bicyclic nucleotides and uses thereof
#3761Use of SIRT7 as novel cancer therapy target and method for treating cancer using the same
#3762Methods of inducing insulin production
#3763Compositions and methods for modulating HBV expression
#3764Nucleic acids for down-regulation of gene expression
#3765Modulation of enhancer RNA mediated gene expression
#3766Amine-containing transfection reagents and methods for making and using same
#3767Antisense modulation of superoxide dismutase 1, soluble expression
#3768Oligomeric compounds and methods
#3769Methods for treating hypercholesterolemia
#3770Methods and means for efficient skipping of at least one of the exons 51-53, 55, 57 and 59 of the human duchenne muscular dystrophy gene
#3771Antisense nucleic acids
#3772Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG
#3773TIKI inhibitors
#3774Methods and compositions for the inhibition of gene expression
#3775Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#3776Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
#3777Compositions and methods for modulating ATP2A2 expression
#3778Modulation of huntingtin expression
#3779Oligonucleotide compounds comprising non-nucleotide overhangs
#3780Treatment of Methionine sulfoxide reductase a (MSRA) related diseases by inhibition of natural antisense transcript to MSRA
#3781Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1
#3782Compounds and methods for altering RSV replication rate
#3783Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisense transcript to CSF3
#3784Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity
#3785MULTIPLE EXON SKIPPING COMPOSITIONS FOR DMD
#3786METHODS AND COMPOSITIONS FOR MODULATING APOLIPOPROTEIN (A) EXPRESSION
#3787THERAPIES FOR CANCER USING RLIP76
#3788Sugar chain-containing polymer, and sugar chain-containing polymer complex
#3789RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
#3790OLIGOMERIC COMPOUNDS COMPRISING BICYCLIC NUCLEOSIDES AND HAVING REDUCED TOXICITY
#3791Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF
#3792Antisense modulation of GCCR expression
#3793COMPOSITIONS AND METHODS FOR MODULATING GENE EXPRESSION
#3794METHODS FOR DIAGNOSING AND TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS
#3795COMPOSITIONS AND METHODS FOR THE TREATMENT OF RADIATION EXPOSURE
#3796USES OF CXCL17, A NOVEL CHEMOKINE MARKER OF HUMAN LUNG AND GASTROINTESTINAL DISEASE
#3797Methods and Uses for Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors
#3798TREATMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
#3799Microsphere-based delivery and ex vivo manipulation of dendritic cells for autoimmune therapies
#3800Compositions for controlling mites in bees
#3801Compositions and methods for modulating hemoglobin gene family expression
#3802Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1
#3803Compositions and methods for inducing myoblast differentiation and myotube formation
#3804COMPOSITIONS AND METHODS FOR MODULATING GENE EXPRESSION
#3805Composition and methods for reduced scarring and treatment of fibrosis
#3806TREATMENT OF CANCER
#3807Compositions and methods for modulating apolipoprotein (a) expression
#3808Compositions and methods for modulating apolipoprotein C-III expression
#3809Conjugated antisense compounds and their use
#3810Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63
#3811Reducing galectin-12 activity to influence the cell function of human sebocytes
#3812Modified small activating RNA molecules and methods of use
#3813Gene targeting methods and tools
#3814RNA products and uses thereof
#3815ANTISENSE COMPOSITION AND METHOD FOR TREATING MUSCLE ATROPHY
#3816Lipid nanoparticle compositions and methods of making and methods of using the same
#3817Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
#3818ISOLATED NOVEL NUCLEIC ACID AND PROTEIN MOLECULES FROM CORN AND METHODS OF USING THOSE MOLECULES TO GENERATE TRANSGENIC PLANTS WITH ENHANCED AGRONOMIC TRAITS
#3819Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics
#3820Methods for the treatment of leber congenital amaurosis
#3821Compositions and methods for decreasing leukocyte extravasation and vessel fluid leakage
#3822Methods for delivery to the central nervous system of nucleic acid nanoparticles to treat central nervous system disorders
#3823Composition for gene delivery
#3824CD147 as receptor for pilus-mediated adhesion of to vascular endothelia
#3825Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
#3826Treatment of Paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1
#3827MicroRNA compounds and methods for modulating miR-122
#3828Antisense compounds targeting genes associated with fibronectin
#3829Nucleic Acid Molecule Capable of Inhibiting Expression of Periostin Gene, method for Inhibiting Expression of Periostin Gene, and Use of Said Nucleic Acid Molecule
#3830LIM kinasemodulating agents for neurofibromatoses therapy and methods for screening for same
#3831ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION
#3832Compositions and methods for gene silencing
#3833Therapeutic agent for treating -associated disease, method for killing parasites, and use thereof
#3834GNAQ targeted dsRNA compositions and methods for inhibiting expression
#3835Antisense modulation of GCGR expression
#3836Compositions and methods for modulating UTRN expression
#3837NOVEL THERAPEUTIC TARGET AND DIAGNOSTIC MARKER FOR ASTHMA AND RELATED CONDITIONS
#3838Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to DMD family
#3839Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFLD)
#3840MODULATION OF LINE-1 REVERSE TRANSCRIPTASE
#3841METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES
#3842Plant germplasm resistant to RNA viruses
#3843Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO
#3844Morpholino-mediated increase in soluble Flt-1 expression results in decreased ocular and tumor neovascularization
#3845Methods and compositions for modulating alpha-1-antitrypsin expression
#3846Peptide-conjugated oligonucleotide therapeutic and method of making and using same
#3847NUCLEIC ACIDS ENCODING INACTIVE VARIANTS OF HUMAN TELOMERASE
#3848Lipid-derived neutral nanoparticles
#38495′ phosphate mimics
#3850Treatment of nuclear respiratory factor 1 (NRF1) related diseases by inhibition of natural antisense transcript to NRF1
#3851Compositions and methods related to protein displacement therapy for myotonic distrophy
#3852Compound and method for treating myotonic dystrophy
#3853Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
#3854Method for treatment of diabetes by a small molecule inhibitor for GRK5
#3855ANTI-NEOPLASTIC USES OF ARTEMIN ANTAGONISTS
#3856NON-CATALYTIC DOMAIN TARGETS IN MATRIX METALLOPROTEASE PROTEINS FOR CANCER THERAPIES
#3857Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
#3858Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNA
#38592′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use
#3860Use of annexin A3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
#3861LM-antibodies, functional fragments, LM-1 target antigen, and methods for making and using same
#3862Compositions and methods for treating otitis media and other conditions with inhibitors of CYLD
#3863THERAPEUTIC TARGETS FOR MITOCHONDRIAL DISORDERS
#3864Methods and compositions for the specific inhibition of MCL1 by double-stranded RNA
#3865Neurofibromatoses therapeutic agents and screening for same
#3866Visfatin therapeutic agents for the treatment of acne and other conditions
#3867Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
#3868Antisense conjugates for decreasing expression of DMPK
#3869Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
#3870Double-stranded oligonucleotides
#3871Methods for the treatment of nonalcoholic steatohepatitis
#3872ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF
#3873COMPOUNDS AND METHODS FOR MODULATING EXPRESSION APOB
#3874SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF
#3875INHIBITORS OF NOX4 EXPRESSION AND /OR NOX4 FUNCTION AND THEIR USE IN THE PREVENTION AND TREATMENT OF NERVE INJURY AND/OR NEUROPATHIC PAIN
#3876Methods and compositions for RNAi-based cancer treatment
#3877Methods for treating eye disorders
#3878Methods for diagnosing and treating neuroendocrine cancer
#3879Combination therapy for cancer using HSP27 inhibitor and EGFR tyrosine kinase inhibitors or anti-folates
#3880Oligomers
#3881RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Duchenne and Becker Muscular Dystrophy
#3882METHOD OF REGULATING CFTR EXPRESSION AND PROCESSING
#3883METHOD FOR IDENTIFICATION OF THE SEQUENCE OF POLY(A)+RNA THAT PHYSICALLY INTERACTS WITH PROTEIN
#3884Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations
#3885Extended dicer substrate agents and methods for the specific inhibition of gene expression
#3886Extended dicer substrate agents and methods for the specific inhibition of gene expression
#3887Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1
#3888Oligonucleotide analog and method for treating flavivirus infections
#3889siRNA compositions and methods for inhibiting gene expression in tumor initiating cells of breast cancer
#3890ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2
#3891Compositions and methods for treatment of ovarian cancer
#3892TREATMENT OF BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO BDNF
#3893METHODS AND COMPOSITIONS FOR MODULATING FACTOR VII EXPRESSION
#3894RHOGEF12 IS A THERAPEUTIC TARGET FOR THE TREATMENT OF HEART FAILURE
#3895Compounds and methods for enhanced cellular uptake
#3896COMPOSITIONS AND METHODS FOR MODULATION OF IKBKAP SPLICING
#3897Aptamer regulated nucleic acids and uses thereof
#3898Pharmaceutical compositions for preventing or treating angiogenic diseases comprising inhibitors of NUP153 gene expression or NUP153 activity as active ingredient
#3899Compositions and methods for the modulation of DNA damage responses using BAL1 and BBAP
#3900Oligomer-conjugate complexes and their use